This session will begin with a conversation with American Cancer Society CEO, Karen Knudsen followed by a panel discussion.

Researchers have made significant progress in treating cancers, with a range of new interventions providing important options for patients. However, for myriad reasons, much of the innovation to date is indicated to treat patients with advanced disease. Today, screening tests are widely available for only five cancer types. For many patients, cancer is diagnosed when they present with symptoms, with the result that treatment is initiated only after the disease has already progressed. A new wave of multi-cancer early detection (MCED) tests has the potential to identify cancers earlier, opening doors to research and treatment opportunities for cancers at earlier stages than before. Learn more about how earlier detection has the potential to shift the research paradigm and drive new advances in cancer treatment.

Part 1:

• Guest Karen Knudsen, CEO, American Cancer Society
• Moderator Michael Milken, Chairman, Milken Institute

Part 2:

• Moderator Jody Hoyos, President and Chief Operating Officer, Prevent Cancer Foundation
• Speaker Jeff Allen, President and CEO, Friends of Cancer Research
• Speaker Camille Hertzka, Vice President, Head of Medical Affairs, US Oncology, AstraZeneca
• Speaker Josh Ofman, Chief Medical Officer and External Affairs, GRAIL
• Speaker Azra Raza, Professor of Medicine and Director, Myelodysplastic Syndrome Center, Columbia University